| Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. | |
| | |
MedLine Citation:
|
PMID: 19808409 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Evolving management of coronary artery disease, heart failure, and the use of implantable cardioverter-defibrillators impacts the characteristics of patients with recurrent ventricular tachycardia (VT). We investigated the substrate, procedure, and outcome evolution of all patients referred for VT ablation during the past 8 years. METHODS AND RESULTS: From 1999 to 2006, 493 consecutive patients (358 male, 57+/-16 years) underwent 623 VT ablations: 131 had no structural heart disease (SHD), 213 had ischemic cardiomyopathies (ICMP), and 149 had nonischemic cardiomyopathies (NICMP). Although the main substrate is ICMP, the proportion of NICMP has increased from 27% to 35% (P=0.06) from 1999-2002 to the 2003-2006. The procedure abolished or modified inducible VTs in > or =75% of patients in all groups, but abolition of all monomorphic VTs was achieved in 125 (83%) patients without SHD, 180 (65%) with ICMP, and 99 (51%) with NICMP (P<0.0001). During a mean follow-up of 3.3+/-2.4 years, no deaths occurred in patients without SHD, but 75 patients (35%) with ICMP and 26 patients (17%) with NICMP died after a median of 13 months. Multivariate Cox regression analysis found that age, ejection fraction, and need for preprocedural mechanical hemodynamic support predicted mortality. CONCLUSIONS: The substrate causing VT in patients requiring ablation is evolving and determines the long-term outcome. In the setting of a normal heart, VT ablation is associated with a low risk of subsequent mortality, with no deaths occurring during a mean follow-up of >3 years. In contrast, in patients with SHD and recurrent VT, VT ablation can be helpful to suppress drug refractory VT, but long-term mortality remains significant. |
| | |
Authors:
|
Frédéric Sacher; Usha B Tedrow; Michael E Field; Jean-Marc Raymond; Bruce A Koplan; Laurence M Epstein; William G Stevenson |
Related Documents
:
|
793369 - Clinical efficacy of amiodarone as an antiarrhythmic agent. 21996409 - Beta-blocker prevents sudden cardiac death in patients with hemodialysis. 9472459 - Exercise stress testing in a community clinic: experience with 38,970 patients. 6199759 - Two-dimensional echocardiographic studies during sustained ventricular tachycardia. 3908329 - Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhy... 10833709 - Diagnosis and management of inadvertently placed pacing and icd leads in the left ventr... 22523119 - Vdra therapy is associated with improved survival in dialysis patients with serum intac... 2387709 - Cardiac arrhythmia in chronic renal failure: holter monitoring during hemodialysis and ... 23609419 - Acute myeloid leukemia associated with fgfr1 abnormalities. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't Date: 2008-06-06 |
Journal Detail:
|
Title: Circulation. Arrhythmia and electrophysiology Volume: 1 ISSN: 1941-3084 ISO Abbreviation: Circ Arrhythm Electrophysiol Publication Date: 2008 Aug |
Date Detail:
|
Created Date: 2009-10-07 Completed Date: 2009-10-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101474365 Medline TA: Circ Arrhythm Electrophysiol Country: United States |
Other Details:
|
Languages: eng Pagination: 153-61 Citation Subset: IM |
Affiliation:
|
Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Cardiomyopathies / complications*, mortality Catheter Ablation / methods* Female Follow-Up Studies Humans Male Middle Aged Myocardial Ischemia / complications*, mortality Prognosis Retrospective Studies Risk Factors Survival Rate / trends Tachycardia, Ventricular / etiology, mortality, surgery* Time Factors United States / epidemiology |
| Comments/Corrections | |
Comment In:
|
Circ Arrhythm Electrophysiol. 2008 Aug;1(3):147-9
[PMID:
19808407
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Atrial arrhythmias after single-ring isolation of the posterior left atrium and pulmonary veins for ...
Next Document: Esophageal injury and temperature monitoring during atrial fibrillation ablation.